Effects of Oxandrolone on clinical outcomes and muscle mass in patients with Septic shock
Phase 2
- Conditions
- Septic ShockC01.757
- Registration Number
- RBR-2hs894w
- Lead Sponsor
- niversidade Estadual Paulista Júlio de Mesquita
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Individuals over 18 years of age; of both genders; hospitalized with a diagnosis of septic shock in the Intensive Care Service of the Hospital das Clínicas da Faculdade de Medicina de Botucatu from October 2023 to June 2025
Exclusion Criteria
Patients with the following characteristics will be excluded: pregnant women; noradrenaline dose > 2.0µg/Kg/min; patients with non-functioning gastrointestinal tract; diagnosis of brain death; patients with a history of previous use of anabolic steroids; association with other types of shock (cardiogenic, hemorrhagic or hypovolemic); patients with breast or prostate cancer and those who spontaneously refuse to participate in the research
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method